Life Sciences 2 min read Dr Reddys launches generic semaglutide in India at 4,200 per month The once-weekly injection, approved by the DCGI, marks the companys entry into GLP-1 therapies as patent expiry opens the market to competition
It works by mimicking a natural hormone in your body called GLP-1 (glucagon-like peptide-1), which regulates appetite and blood sugar levels
Lancet Diabetes Endocrinol 6(11):859869 Mann JFE, rsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S et al (2017) Liraglutide and renal outcomes in type 2 diabetes
Three steps to your personalised protocol
The right answer is individual
Try this: Eat smaller, more frequent meals throughout the day rather than three large ones